(Teaching unit shared with the ICM curriculum, Biomedical engineering major.)
Students will follow an introduction to the emerging and inter-disciplinary discipline of nanomedicine. They will in addition be made aware of health risks at work.
| On completion of the unit, the student will be capable of: | Classification level | Priority |
|---|---|---|
| Acquiring the basic concepts of the emerging and inter-disciplinary disciplines of nanomedicine and nanotoxicology | 2. Understand | null |
| Raising awareness of health risks in a company environment and in particular oncogenic risks (prevention methods, risk management…) | 4. Analyse | null |
| Acquiring knowledge in the physico-chemistry of solids in order to understand the impact of these parameters on vectorisation (notion of bio-distribution) or the biological activity (toxicity) of nanoparticles | 5. Summarise | null |
| Percentage ratio of individual assessment | Percentage ratio of group assessment | ||||
|---|---|---|---|---|---|
| Written exam: | 100 | % | Project submission: | % | |
| Individual oral exam: | % | Group presentation: | % | ||
| Individual presentation: | % | Group practical exercise: | % | ||
| Individual practical exercise: | % | Group report: | % | ||
| Individual report: | % | ||||
| Other(s): % | |||||
| Type of teaching activity | Content, sequencing and organisation |
|---|---|
| Course | As a form of introduction students will study the definitions and framework of nanomedicine. They will also see the nanomaterials used in nanomedicine (the different types, properties, applications). They will refer to physico-chemical aspects (nanomaterial synthetics) and biological aspects (what becomes of nanoparticles in the organism). Finally they will study application examples (nanovectorisation, drug delivery). Students will be made aware of health risks in a company environment. In particular the prevention approach to oncogenic risks will be presented by describing chemical, biological and physical risks. |